Clinical Trials

NCT05467527 | COMPLETED | NA
196 participants

PACT Programme for Parents of Children With SHCN

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-06-27
Completion:
2025-11-30
Conditions
  • Urologic Diseases
  • Gastrointestinal Diseases
  • Vascular Diseases
  • Cleft Lip and Palate
  • Neurodevelopmental Disorders
  • Attention Deficit Hyperactivity Disorder
  • Autism Spectrum Disorder
  • Developmental Delay
Interventions
  • BEHAVIORAL
No Results Yet
NCT05460468 | RECRUITING | NA
150 participants

Neuromodulation of Memory in Aging

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2024-03-28
Completion:
2027-06-30
Conditions
  • Mild Cognitive Impairment
  • MCI
Interventions
  • DEVICE
No Results Yet
NCT05422794 | RECRUITING | PHASE1
57 participants

Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-05-18
Completion:
2027-03-31
Conditions
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Locally Advanced Triple-Negative Breast Carcinoma
  • Metastatic Triple-Negative Breast Carcinoma
  • Unresectable Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT05388110 | TERMINATED
14 participants

SKY Breath Intervention

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-11
Start Date:
2022-04-22
Completion:
2023-12-31
Conditions
  • Depression
  • Anxiety Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05327608 | RECRUITING | PHASE2
55 participants

Neoadjuvant Breast Cancer Time Restricted Eating

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-07-28
Completion:
2027-05-01
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Breast Ductal Carcinoma in Situ
  • HER2 Negative Breast Carcinoma
  • Hormone Receptor Positive Breast Carcinoma
  • Invasive Breast Carcinoma
Interventions
  • OTHER
No Results Yet
NCT05256225 | RECRUITING | PHASE3
360 participants

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-11-16
Completion:
2027-10-31
Conditions
  • Endometrial Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Dedifferentiated Carcinoma
  • Endometrial Endometrioid Adenocarcinoma
  • Endometrial Mixed Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Endometrial Undifferentiated Carcinoma
  • Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
Interventions
  • PROCEDURE
  • DRUG
  • RADIATION
  • OTHER
No Results Yet
NCT05232825 | COMPLETED | PHASE3
236 participants
NCT05201534 | RECRUITING | NA
180 participants

Interventions in Mathematics and Cognitive Skills

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-05-05
Completion:
2027-08-31
Conditions
  • Math Learning Disability
  • Child Development
  • Developmental Disability
  • Learning Disabilities
  • Learning Disabled
  • Learning Curve
  • Mathematics Disorder
  • Dyscalculia
  • Dyscalculia, Primary
  • Dyscalculia, Acquired
  • Specific Learning Disorder, With Impairment in Mathematics
  • Individuality
  • Behavior, Child
  • Behavior and Behavior Mechanisms
  • Behavior
  • Decision Making
  • Neuronal Plasticity
  • Cognition
  • Cognition Disorder
  • Cognitive Dysfunction
  • Cognitive Change
  • Cognitive Impairment, Mild
  • Cognitive Developmental Delay
  • Cognitive Orientation
  • Cognitive Delay, Mild
  • Cognitive Deficits, Mild
  • Cognitive Abnormality
  • Neuroscience
Interventions
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page